CD163 and kidney disorder: Given that urine sCD163 is predictive of concurrent proliferative LN in patients with clinically active renal disease, and given its association with active crescent formation and interstitial inflammation, monitoring urine sCD163 might represent a convenient, non-invasive method to track underlying renal disease in patients with LN.